XTL Biopharmaceuticals Ltd (XTLB)
2.57
-0.09
(-3.39%)
USD |
NASDAQ |
May 23, 16:00
2.57
0.00 (0.00%)
After-Hours: 20:00
XTL Biopharmaceuticals Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.013M |
| June 30, 2014 | 0.066M |
| March 31, 2014 | 0.23M |
| December 31, 2013 | 0.172M |
| September 30, 2013 | 0.127M |
| June 30, 2013 | 0.009M |
| March 31, 2013 | 0.009M |
| December 31, 2012 | 0.082M |
| September 30, 2012 | 0.395M |
| June 30, 2012 | 0.036M |
| Date | Value |
|---|---|
| March 31, 2012 | 3.77M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | -0.007M |
| June 30, 2011 | -0.015M |
| March 31, 2011 | 1.766M |
| September 30, 2010 | 1.473M |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | 0.00 |
| BioLine Rx Ltd | 11.74M |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | 38.98M |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow Yield | -17.71% |